Notes
Comparative Effectiveness Public Advisory Council
References
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document on AVXS-101 and Nusinersen for Spinal Muscular Atrophy Internet Document : 22 Aug 2018. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-review-posts-draft-scoping-document-on-avxs-101-and-nusinersen-for-spinal-muscular-atrophy/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Releases Draft Evidence Report on Long-term Treatments for Prevention of Hereditary Angioedema Attacks. Internet Document : 23 Aug 2018. Available from: URL: https://icer-review.org/announcements/hae-draft-report/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Report Finds Evidence Inadequate to Distinguish the Clinical Benefits of Different Antiandrogen Therapies for Men with Nonmetastatic Castration-Resistant Prostate Cancer. Internet Document : 24 Aug 2018. Available from: URL: https://icer-review.org/announcements/prostate-cancer-evidence-report/.
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Finds Current List Price of Patisiran for Amyloidosis Far Exceeds Standard Cost-Effectiveness Levels. Internet Document : 29 Aug 2018. Available from: URL: https://icer-review.org/announcements/amyloidosis-evidence-report/.
Rights and permissions
About this article
Cite this article
More news from ICER. PharmacoEcon Outcomes News 811, 1–2 (2018). https://doi.org/10.1007/s40274-018-5230-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5230-6